Bristol-Myers Squibb Co (BMY) Analysts See $0.75 EPS

Cornelia Mascio
Ottobre 13, 2017

The Dynamic Advisors Solutions Llc holds 17,365 shares with $968,000 value, up from 7,675 last quarter. The stock rose 1.04% or $0.52 reaching $50.06. One Capital Management Llc bought 15,453 shares as the company's stock declined 1.04% while stock markets rallied. It is down 18.66% since October 13, 2016 and is uptrending. It has underperformed by 16.70% the S&P500. Bristol-Myers Squibb Company had 57 analyst reports since July 28, 2015 according to SRatingsIntel.

Barclays this morning upped its price target on Bristol-Myers Squibb Co (NYSE:BMY) to $65 from $58, sending the shares to their highest point since their August 2016 bear gap. Salient Advisors Ltd Co holds 7,750 shares. At last check, BMY stock was up 0.4% at $65.60, earlier topping out at $66.10, putting it above a key technical level.

Cadence Capital Management Llc increased Foot Locker Inc (NYSE:FL) stake by 9,059 shares to 49,829 valued at $2.46M in 2017Q2. Bristol-Myers Squibb Company (NYSE:BMY) has noticeable measure of stock volatility, for this average true range is an exponential moving average (14 trading days) of the True Ranges. It has underperformed by 39.89% the S&P500. Investors of record on Friday, October 6th will be issued a dividend of $0.39 per share. Its up 0.87, from 1.52 in 2017Q1. It is negative, as 78 investors sold BMY shares while 520 reduced holdings. 15 funds opened positions while 28 raised stakes. Kazazian Asset Mngmt Limited Com reported 1.28% of its portfolio in Bristol-Myers Squibb Co (NYSE:BMY). 10,850 were accumulated by Banque Pictet And Cie Sa. Bristol Myers Squibb Co now has $107.38B valuation. The institutional investor held 38,514 shares of the major pharmaceuticals company at the end of 2017Q2, valued at $2.15 million, up from 23,061 at the end of the previous reported quarter. Telos Cap stated it has 0.32% of its portfolio in Bristol-Myers Squibb Co (NYSE:BMY). The California-based Wells Fargo Mn has invested 0% in Stemline Therapeutics Inc (NASDAQ:STML). Deutsche Bank Ag accumulated 286,979 shares.

Bristol-Myers Squibb Company's average Book Value per Share Growth Rate was 0.4 percent during the past 12 months. Modera Wealth Mgmt Lc owns 5,371 shares. For BMY, the company now has $3.47 Billion of cash on the books, which is offset by $1.31 Billion current liabilities. Roof Eidam And Maycock Adv holds 6,486 shares or 0.19% of its portfolio. Bancshares Of America De invested in 22 shares or 0% of the stock. SYEV's SI was 2,100 shares in October as released by FINRA. Netflix Inc (Call) was raised too. On average, equities research analysts anticipate that Bristol-Myers Squibb Company will post $2.98 earnings per share for the current year. Therefore 32% are positive. The correct version of this report can be viewed at

FCF is an indicator of a firm's financial performance, measured as operating cash flow minus capital expenditures. The company was upgraded on Tuesday, September 29 by UBS. The firm earned "Buy" rating on Thursday, July 27 by Leerink Swann. The firm earned "Sell" rating on Monday, June 5 by BMO Capital Markets. Stifel Nicolaus maintained it with "Hold" rating and $9 target in Wednesday, November 16 report. Of those analysts, 6 rate stock as a Strong Buy, 6 rate it as Hold, and just no analyst rates it as a Moderate Sell. Therefore 41% are positive. The rating was initiated by Atlantic Securities with "Underweight" on Friday, December 18. The stock of ConocoPhillips (NYSE:COP) earned "Buy" rating by Piper Jaffray on Thursday, August 24. On Thursday, August 27 the stock rating was maintained by Jefferies with "Hold". BMO Capital Markets maintained the shares of BMY in report on Monday, June 5 with "Sell" rating. The rating was downgraded by JMP Securities to "Market Perform" on Tuesday, August 9. (NYSE:VZ) to report earnings on October, 19 before the open. A score above three means the company is not likely to go bankrupt, while score less than 1.8 suggests the firm is probably headed for bankruptcy. Moreover, Rhumbline Advisers has 0.05% invested in Hess Corp. It fall, as 33 investors sold LEA shares while 186 reduced holdings. Of those holders, 678 had increased positions amounting to 65.23 million shares, 735 had decreased positions amounting to 94.32 million shares, and 256 holders have a held position accounting for 987.15 million shares. 822.50 million shares or 0.21% more from 820.79 million shares in 2017Q1 were reported. Point72 Asset Management LP reported 0.03% stake. Goldman Sachs Grp Inc holds 0% of its portfolio in Walker & Dunlop, Inc. Bluecrest Mngmt holds 10,931 shares. Tru Of Vermont has 0% invested in Hess Corp. Waddell Reed Fincl reported 0.04% in ConocoPhillips (NYSE:COP). (NYSE:HES). Trillium Asset Management Ltd Com owns 63,356 shares. Highland Cap holds 2,587 shares or 0.03% of its portfolio. Stevens First Principles Invest Advsrs reported 777 shares. Schroder Invest Mngmt Group Incorporated has 817,412 shares. Vanguard Group accumulated 963,235 shares or 0% of the stock. NN Investment Partners Holdings N.V. now owns 1,581,454 shares of the biopharmaceutical company's stock worth $88,119,000 after purchasing an additional 802,931 shares during the period. Illinois-based Hightower Limited Company has invested 0% in Oclaro Inc (NASDAQ:OCLR). Pinnacle Associate Limited, New York-based fund reported 272,224 shares.

Analysts await Verizon Communications Inc.

Altre relazioniGrafFiotech

Discuti questo articolo

Segui i nostri GIORNALE